We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CVKD market cap is 6.76M. The company's latest EPS is USD -0.5220 and P/E is -0.86.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | ||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.2M | -1.03M | -1.14M | -1.26M | -1.76M |
| Net Income | -5.17M | -1M | -1.04M | -1.14M | -1.66M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -2.7M | -7.63M |
| Net Income | -6.71M | -8.36M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | ||||
| Total Assets | 4.48M | 3.56M | 9.31M | 8.52M | 7.05M |
| Total Liabilities | 417k | 383k | 566k | 827k | 856k |
| Total Equity | 4.07M | 3.18M | 8.75M | 7.69M | 6.19M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Assets | 778k | 8.52M |
| Total Liabilities | 6.33M | 827k |
| Total Equity | -5.55M | 7.69M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | ||||
| Operating | -1.41M | -2.21M | -2.84M | -3.53M | -1.84M |
| Investing | N/A | -3k | -3k | -3k | N/A |
| Financing | 5.41M | 5.41M | 11.92M | 11.9M | N/A |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Operating | -1.2M | -3.53M |
| Investing | -2k | -3k |
| Financing | 1.24M | 11.9M |
| Market Cap | 6.76M |
| Price to Earnings Ratio | -0.86 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.86 |
| Price to Book Ratio | 0.94 |
| Dividend Yield | - |
| Shares Outstanding | 16.01M |
| Average Volume (1 week) | 56.93k |
| Average Volume (1 Month) | 73.11k |
| 52 Week Change | -51.44% |
| 52 Week High | 2.17 |
| 52 Week Low | 0.36 |
| Spread (Intraday) | 0.03 (6.11%) |
| Company Name | Cadrenal Therapeutics Inc |
| Address |
651 n broad st suite 201 middletown, delaware 19709 |
| Website | https://www.cadrenal.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
